Pfizer’s COVID Antiviral Pill Is Important Step Toward Outbreak Of Pandemic: Joe Biden.
Highlight
- Getting vaccinated, booster shot to remain most important tool to save lives: Biden
- Once the pills become widely available it will be a significant step forward: US President Biden
- PAXLOVID reduced the risk of hospitalization or death from any cause by 88 pc compared to placebo
US President Joe Biden said Tuesday (local time) that Pfizer’s COVID-19 antiviral pill is an important step on the way out of the pandemic.
“I am encouraged by the promising data released by Pfizer today, showing that its antiviral pill is effective in reducing the risk of serious illness in people infected with COVID-19. This news is yet another potential step in our fight against the virus. provides powerful tools, including Omicron Edition,” read a statement from the president on Pfizer’s COVID-19 antiviral pill.
“Getting vaccinated and getting our booster shot remains the most important tool we have to save lives. But if this treatment is really authorized—and once the pills become widely available—it’s out of the epidemic.” will mark an important step forward in our path to exit,” the statement added.
Earlier on Tuesday, Pfizer announced additional Phase 2/3 study results confirming the strong efficacy of a novel COVID-19 oral antiviral treatment candidate in reducing the risk of hospitalization or death. The end result from an analysis of all 2,246 adults enrolled in its Phase 2/3 EPIC-HR (Evaluation of Protease Inhibition for COVID-19 in High-Risk Patients) trial of its novel COVID-19 oral antiviral candidate PAXLOVID™. [nirmatrelvir (PF-07321332) tablets and ritonavir tablets] were in line with interim analysis announced in November 2021 showing that paxlovid reduced the risk of hospitalization or death from any cause by 89 percent in non-hospitalized, high-risk adult patients with COVID-19 Treated with-19 within three days. symptom onset, the Pfizer release said.
“In a secondary endpoint, paxlovid reduced the risk of hospitalization or death from any cause by 88 percent compared to placebo in patients treated within five days of symptom onset, the interim analysis observed. 85 percent increase,” it added. release.
EPIC-HR data has been shared with the US Food and Drug Administration (FDA) as part of an ongoing rolling submission for emergency use authorization (EUA). Meanwhile, Biden said there are several steps to be taken before the Pfizer pill becomes available, including authorization by the Food and Drug Administration.
“To make sure we’re prepared, my administration has ordered enough of these pills to treat 10 million Americans,” Biden said.
He further reiterated that a combination of widespread vaccinations and boosters, tests and effective pills for those who do get sick will help further reduce the impact of COVID-19 on lives and the economy as the US continues to build better.
(with ANI inputs)
,